Analysts expect over 2018 rising revenue Getinge

Tomorrow the Swedish Getinge will publish its past quarter's figures. For this year Getinge 's revenue will be around 23,84 billion SEK. This is according to the average of the analysts' estimates. This is slightly more than 2017's revenue of 22,5 billion SEK.

Historical revenues and results Getinge plus estimates 2018

financial analysis

The analysts expect for 2018 a net profit of 1,39 billion SEK. For this year the majority of the analysts, consulted by press agency Thomson Reuters, expects a profit per share of 5,14 SEK. So the price/earnings-ratio equals 15,2.

Per share the analysts expect a dividend of 1,43 SEK per share. Getinge 's dividend yield thus equals 1,83 percent. The average dividend yield of the pharmaceutical companies equals a moderate 0,5 percent.

Based on the current number of shares Getinge 's market capitalization equals 17,63 billion SEK. The Getinge stock was the past 12 months quite unstable. Since last October the stock is 39 percent lower. This year the stock price moved between 75 and 139 SEK. Since 2008 the stock price is almost 12 percent lower.

At 10.16 the stock trades 1,05 percent higher at 78,14 SEK.

Historical stock prices Getinge

financial analysis getinge

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.